The FDA has not authorized the use of Molnupiravir in patients younger than 18 years of age due to the possibility that it may affect bone and cartilage growth. It is also not recommended for use in pregnant women in light of evidence from animal studies that it may cause fetal harm. The FDA said that a healthcare provider can however administer the drug if it deems that the benefits outweigh the risks for that individual patient, and after it has obtained informed consent from the patient.<\/p>\n\n\n\n
Besides the US, the UK<\/a> and Bangladesh<\/a> have approved Molnupiravir for emergency use.<\/p>\n","post_title":"Anti-Coronavirus Pill gets Emergency Use Authorization from the FDA","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"open","post_password":"","post_name":"anti-coronavirus-pill-gets-emergency-use-authorization-from-the-fda","to_ping":"","pinged":"","post_modified":"2021-12-29 17:23:46","post_modified_gmt":"2021-12-29 11:53:46","post_content_filtered":"","post_parent":0,"guid":"https:\/\/sapienjournal.org\/?p=1805","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":false,"total_page":1},"paged":1,"column_class":"jeg_col_3o3","class":"jnews_block_9"};